What does multiple myeloma look like? Can it be cured?

1. None, anti-tumor chemotherapy is still the mainstay. (1) M2 regimen: carachlorethamine 20mg m2 intravenous injection, cyclophosphamide 400mg m2 intravenous injection on day 1, day 1; chlorambucil phenylpropionate 4 mg m2 daily orally on day 1 7 and 10 mg m2 orally daily on day 1 4; Prednone 40 mg m2 orally daily on days 1 7 and 20 mg orally daily on days 8 to 14.

The 21st day is 1 course of treatment, and the 2 courses are exhausted for 14 days, a total of 6 courses. Prednisone is gradually discontinued from the 3rd or 4th course of treatment. For patients who have developed resistance, refractory or advanced multiple myeloma to the M2 regimen, VAD regimens can be used

Vincristine 1 mg intravenously, once a day for 4 days; Doxorubicin 10 mg intravenously once a day for 4 days; Dexamethasone 10 mg intravenously, once a day for 4 days, then applied on 9 12 days, 17 21 days, and repeated every 25 days. If combination chemotherapy cannot be tolerated, it can be used alone or alone. (2) Interferon:

A 2a interferon 3 10u intramuscularly, daily increasing doses of 6 10u, 9 10u, 18 10u to 50 10u, severe reaction or ** more than 4 weeks without effect. (3) Anemia and infection can be difficult to give symptomatic anti-anemia and anti-infection**. (4) Plasma fractionation can be performed for hyperserum viscosity; Hypercalcemia can be given normal saline 1000 ml intravenously, prednisone 20 mg orally times a day or hydrocortisone 200 to 300 mg intravenously daily.

5) Bone marrow transplant. After resolution of high-dose chemotherapy, autotherapy or allogeneic bone marrow transplantation may be considered. Hope it works for you.

Malignant tumors originating from bone marrow hematopoietic tissues and plasma cell hyperplasia. It can cause bone destruction, anemia, renal impairment, and immune dysfunction. There is an indefinite asymptomatic period, and a small number of patients have back pain as the first symptom, pathological fractures, hypercalcemia, anemia, and cachexia.

X-rays show multiple lytic destruction and extensive osteoporosis. Chemotherapy and radiotherapy, prevention of infection and renal failure are important to improve the survival rate of myeloma, and the prognosis of this disease is poor.

Multiple myeloma is a malignant plasma cell disease that is more likely to occur in middle-aged people over 40 years old, especially those in their 60s. Multiple myeloma, if it is detected early, it can also be intervened early, and if it is detected late, it will be carried out by hematopoietic stem cell transplantation or radiotherapy

Asymptomatic patients with multiple myeloma do not need to be, only after symptoms appear, they need to start**. For those high-risk patients with asymptomatic myeloma, there is a high probability that they will develop multiple myeloma within two years, and if detected early, early intervention can also be achieved**. For high-risk asymptomatic multiple myeloma, there is a certain definition in medicine, for example, abnormal plasma cells in the bone marrow must be greater than 60%, the ratio of serum free light chain must be greater than 100, etc., for people who do not understand medicine, there is no need to care so much, we just need to listen to the doctor's advice.

Because multiple myeloma is prone to cause a series of complications, such as hemoglobin less than 60 grams per liter, renal failure, hyperviscosity, etc., medical will be based on the complications to carry out the corresponding **, and this **way is also general**. Chemotherapy can be given for multiple myeloma, but the commonly used drugs are targeted drugs, or traditional chemotherapy drugs. Hematopoietic stem cell transplantation can also be performed, which is generally recommended for those who are able.

If conditions permit, a subset of young high-risk patients can also undergo allogeneic hematopoietic stem cell transplantation**. Finally, we can also use radiotherapy, which is mainly used for patients with localized myeloma, local bone pain or spinal cord compression. In fact, for multiple myeloma, if it is detected early, it can be detected early, and the possibility of recovery will naturally increase greatly.

If there are inexplicable pathological fractures, bone pain, bone deformation, anemia and bleeding and other symptoms on the body, it is necessary to go to the hospital in time.

Go to the hospital for chemotherapy, you can also go for a stem cell transplant, on the basis of chemotherapy, you can also use bisphosphonates to inhibit the growth of cancer cells, eat more high-protein things in your diet, eat more light things, have a good attitude, and do some exercises every day to enhance your resistance.

It can only be done through surgery**, and there can be some physical treatment**, or it can be through physiotherapy and chemotherapy. Or drink some medicine, or do some stem cell transplantation.

You can go directly to the hospital, and then explain your situation to the doctor, and the doctor will make a set of ** plans according to your situation.

Can multiple myeloma be cured? Now it is believed that on the platform of drugs, multiple myeloma is still a disease that cannot be abided, that is to say, this disease will be a** sooner or later. For patients with multiple myeloma, there are several factors to consider

One is tumor burden, which is manifested in the stage of the tumor, and the more advanced the load, the greater the burden.

There is also the situation of the patient, most of the myeloma patients are elderly patients, and they can have a variety of underlying diseases, coupled with the elevation of myeloma-related monoclonal immunoglobulin, as well as amyloidosis, etc., which can further exacerbate the decline of organ function, and whether it can tolerate strong ** needs to be specifically evaluated.

The third is the biological characteristics of the disease, some myeloma with relatively high-risk cytogenetic abnormalities, in this case, it indicates that the disease progresses rapidly, the process is aggressive, and the long-term results are not good.

The fourth is to look at the availability of new drugs and the patient's response. In recent years, many new drugs have been developed and marketed in the research field of multiple myeloma, which has greatly improved the disease control rate of myeloma patients and improved the quality of life and survival time of patients. If the patient accepts these new drugs** or a combination of new drugs**, the overall response can generally be improved on the original basis**, and the better the response to the efficacy**, the better the long-term survival is likely.

Hello; **Multiple myeloma is recommended that you can take a combination of traditional Chinese and Western medicine**. **On the one hand, Western medicine should be used to stop the disease to inhibit the killing of abnormally proliferated plasma cells, and at the same time, traditional Chinese medicine must be carried out**. On the one hand, traditional Chinese medicine** can enhance the body's immune function, and on the other hand, it can kill and induce differentiated myeloma cells to transform them into normal cells (mature plasma cells).

Multiple myeloma is a refractory blood disease, and patients can be treated with traditional Chinese medicine combined with bone marrow transplantation or traditional Chinese medicine combined with chemotherapy, which can improve the rate.

Hello; In view of this situation, it is very good to add traditional Chinese medicine on the basis of the original plan, which can not only effectively alleviate the quality of Western medicine, but also regulate the overall condition of the patient.

Multiple myeloma is a blood cancer associated with lymphoma and leukemia, and it is unlikely to be cured, because myeloma is a malignant tumor after all. In the process of being positive, we must also have full psychological preparation. Currently, survival can be significantly prolonged by **.

However, the patient needs to pay close attention to the changes in renal function and be alert to the occurrence of renal failure. It is recommended to pay attention to rest, strengthen nutrition, and eat high-protein foods. The survival time of patients depends on whether the patient's response to the drug is timely, and the response of different patients to the drug, the occurrence of complications and survival are very different, the short ones only survive for a few months, and the elderly can survive for more than 10 years.

At present, this disease cannot be completely completed regardless of whether it is traditional Chinese medicine or Western medicine, nor can it be combined with traditional Chinese and Western medicine. At present, no amount of capsules can be completely cured. , but it doesn't mean that there is no need for **, this disease can be used to alleviate symptoms as much as possible and prolong life.

At present, the effect of this disease is relatively good with the combination of traditional Chinese and Western medicine, and the specific medication is different for each person, so it is necessary to go to the hospital to determine in detail.

Multiple myeloma is a very malignant tumor that has so far been unable to **. Because it is a hematologic malignant tumor, although there is no current best method, but through the emergence of new chemotherapy drugs bortezomib, lenalidomide, CD38 monoclonal antibody targeted drugs and the development of hematopoietic stem cell transplantation technology, most patients can obtain a more satisfactory effect, at least prolonging the survival time, and the 5-year survival rate reaches more than 60%.

Is multiple myeloma easy to treat? How long can you live with myeloma? First of all, we need to know what is myeloma?

Myeloma is a disease caused by abnormal growth of mesocellular cells within the bone marrow. It is mainly manifested as the destruction of bones caused by static toughness; Abnormal globulins are high, and a decrease in normal immunoglobulins causes a decrease in resistance; Secrete some abnormal globulins, which also have some damage to the kidneys. Multiple myeloma has a slow onset and no obvious symptoms in the early stage, which is easy to be misdiagnosed.

The clinical manifestations of MM are diverse, including anemia, bone pain, renal insufficiency, infection, bleeding, neurological symptoms, hypercalcemia, amyloidosis, etc.

Can so many myeloma be cured?

Multiple myeloma is a malignant tumour and something must be done to stop it from getting worse. The two main ways are chemotherapy and radiotherapy. The patient has severe pain, it is useless to take painkillers, and painkillers also hurt the kidneys, which cannot solve the fundamental problem.

We should be diagnosed as soon as possible, and if the body allows, we should proceed with chemotherapy as soon as possible. The effect of chemotherapy is relatively good. It depends on the severity of the patient's multiple myeloma to determine the patient's survival time.

Multiple myeloma is a kind of plasma cell tumor, which is not possible so far, and commonly used drugs include targeted drugs such as proteasome inhibitors, immunomodulators, traditional Chinese medicine and traditional chemotherapy drugs such as melphalan, doxorubicin, etc. Autologous hematopoietic stem cell transplantation is suitable for all patients, and young high-risk patients with good physical fitness can be considered for allogeneic hematopoietic stems.

So how long can you live with myeloma?

There are many types of myeloma, the severity of the disease is also differentiated, and the mentality is also very different, so there is no definite answer, which is related to many factors, and it must be judged according to the development of the patient's condition. In the early stages, patients have pain symptoms, which are characterized by a long duration and progressive exacerbation, and as the disease progresses, some patients end up in pain. Therefore, the survival of myeloma patients cannot be generalized, and it has a lot to do with the patient's physique, age, mentality and method, and each factor will affect the survival of the patient.